Depression: Another side effect of toxic vaccinations?

If it seems like a lot of people you know are suffering from depression, it’s probably not your imagination: The World Health Organization reports that roughly 300 million people around the world are dealing with the disorder, and other studies show that 16.2 million American adults experienced a major depressive episode at least once during the past year.

It’s a serious problem that can have a very negative impact on your quality of life. It is characterized by at least two weeks of depressed mood and a loss of interest in activities, along with symptoms like sleeping problems, appetite or weight changes, lower energy, difficulty with concentration, slow physical movements, or thoughts of or attempts at suicide.

Depression is also increasingly affecting children, with statistics showing that up to three percent of kids aged six to 12, and eight percent of teenagers could be suffering from serious depression. Why is depression suddenly becoming such a big problem?

Psychiatrist Kelly Brogan thinks vaccines could be contributing to depression in a surprising way. Her research points to the possibility that an aluminum adjuvant used in more than 18 common childhood vaccines is causing the long-term brain inflammation linked to depression, with Gardasil being one of the biggest culprits.

Dr. Brogan cites several other studies that support this connection. One study, which looked at 41 undergraduate students, found that nearly every subject who had been given the flu jab had a rise in blood levels of the anti-inflammatory myokine IL-6, and those with the largest rises had become more depressed and confused.

She’s hardly the only person who thinks this way; another study has found that the rise in vaccines injected into infants whose immune systems and central nervous systems are still developing is also playing a role. According to the Giannotta paper, several vaccines can be linked to neuroinflammation, and in turn, depression.

It’s not surprising, then, that a study published in Frontiers in Psychiatry found that patients who were diagnosed with neuropsychiatric problems like anorexia nervosa and obsessive-compulsive disorder were more likely to have gotten a vaccine within the three months leading up to their diagnosis. The influenza vaccine in particular was linked to a higher rate of anxiety disorder, tic disorder, anorexia, and obsessive-compulsive disorder.

The study’s authors said that they believed the body’s immune response to the vaccines could be responsible for this effect. Vaccines prod the immune system to generate antibodies against bacteria and viruses, and sometimes these antibodies cross-react with human brain proteins. They also say that children who are experiencing inflammation at the time of their vaccination could see a particularly strong effect on brain development, although their study did not look into vaccination timing specifically. There may also be a genetic factor at play, and some doctors even believe the act of getting the vaccine could be traumatizing enough to sensitive children to spur psychological conditions. The study’s authors would like to see further studies carried out in order to explore this connection in more depth.

Aluminum is everywhere

It’s not just vaccines that are bombarding us with neurotoxic aluminum; it is also found in many medications, cosmetics, cleaning products, and soft furnishings, giving people a tremendous dose of this very dangerous substance. Unfortunately, it’s hard to avoid the second most-used metal on the planet after steel.

With depression now the leading cause of disability worldwide, it’s surprising that researchers aren’t looking more into the connection between vaccines and depression. Of course, it works out quite well for the pharmaceutical companies that profit from the vaccines and the antidepressants that many people will end up needing as a result of vaccination.

See for more investigative reporting on influenza vaccinations.

Sources for this article include:

comments powered by Disqus